Age-specific all-cause mortality rates among adolescents and youth living with and without HIV: evidence from a cohort study in South Africa

dc.contributor.authorKnight, Lucia
dc.contributor.authorZhou, Siyanai
dc.contributor.authorToska, Elona
dc.date.accessioned2025-10-13T09:03:31Z
dc.date.available2025-10-13T09:03:31Z
dc.date.issued2025
dc.description.abstractIntroduction: Mortality among adolescents living with HIV (ALHIV) remains a global health problem. We lack granular (age- and sex-disaggregated) data on mortality among ALHIV, hence, this study aims to assess all-cause mortality among ALHIV in a low-resource setting. Methods: All adolescents ever initiated on antiretroviral treatment (ART, N = 1107) and their HIV-negative peers (N = 456) aged 10–19 years, recruited as part of the Mzantsi Wakho study cohort, were followed up between 2014 and 2022 (yielding 12,427.7 person-years of follow-up). First, we assessed the proportion of deaths and estimated crude mortality incidence rates per 100 person-years of follow-up and their 95% confidence intervals, stratified by HIV status, sex and mode of HIV acquisition (vertical vs. sexual). We then estimated adjusted incidence rate ratios (IRRs) using Poisson regression adjusted for time-varying age, sex and time on ART. Last, we used the Cox proportional hazards regression model to estimate the risk of death by ART adherence. Results: A total of 1563 adolescents and young people were included in this analysis, 70.8% ALHIV and 57% female. More deaths occurred in ALHIV compared to their HIV-negative peers (8.3% vs. 0.4%, p<0.001). Among ALHIV, we observed a significantly higher proportion of deaths among males compared to females (10.7% vs. 7.1%, p = 0.036). Overall, mortality increased significantly with age, and males had a higher risk of mortality compared to females. Adolescents and youth living with vertically acquired HIV had a higher risk of mortality than those living with sexually acquired HIV. Comparing mortality rates by mode of HIV acquisition stratified by age and sex, mortality risk was higher among females aged 20+ years with vertically acquired HIV (IRR: 3.61, 95% CI 1.48–8.82) compared to females with sexually acquired HIV of the same age group. In a sub-sample analysis, sustained ART adherence was associated with a lower risk of death (aHR: 0.44, 95% CI 0.23–0.85).
dc.identifier.citationZhou, S., Toska, E., Gwampi, B., Johnson, L.F., Tolmay, J., Saal, W., Leon, Z., Knight, L. and Cluver, L., 2025. Age‐specific all‐cause mortality rates among adolescents and youth living with and without HIV: Evidence from a cohort study in South Africa. Journal of the International AIDS Society, 28(6), p.e26522.
dc.identifier.urihttps://doi.org/10.1002/jia2.26522
dc.identifier.urihttps://hdl.handle.net/10566/21075
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.subjectAdolescents
dc.subjectAll-Cause Mortality
dc.subjectAntiretroviral Adherence
dc.subjectAntiretroviral Treatment
dc.subjectSouth Africa
dc.titleAge-specific all-cause mortality rates among adolescents and youth living with and without HIV: evidence from a cohort study in South Africa
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
knight_age_specific_all_cause_mortalitya_2025.pdf
Size:
529.91 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: